Showing results (1281-1290 of 1,650) with videos related to
Sort By:
Pageof 165
Therapeutic Innovation & Regulatory Science|August 31, 2023
Analysis on the Marketing Trend and Approval Lag of Imported Orphan Drugs from 2010 to 2021 in ChinaFeifei Peng, Hang ZhengTherapeutic Innovation & Regulatory Science|September 8, 2023
Planning Benefit-Risk Assessments Using VisualizationsMichael W Colopy, Lovemore Gakava, Chen ChenTherapeutic Innovation & Regulatory Science|August 8, 2023
A Mixed Methods Study to Explore Relevant Metrics for a Results Framework Measuring the Public Health Impact of Reliance-Based PathwaysInez Adams, Patricia A Cuff, Lawrence LibertiTherapeutic Innovation & Regulatory Science|August 9, 2023
Statistical Evaluation of Responder Analysis in Stem Cell Clinical TrialsJiajun Liu, Emily Poehlein, Shein-Chung ChowTherapeutic Innovation & Regulatory Science|August 24, 2023
Aiding the Adoption of Master Protocols by Optimizing Patient EngagementRaymond A Huml, Deborah Collyar, Zoran Antonijevic, et al.Therapeutic Innovation & Regulatory Science|August 17, 2023
Strategy for Generating Blinded Evidence for Single-Arm Trials with External Controls Using Expert Review of Home VideoXinruo Zhang, Katherine Brind'Amour, Kelly E King, et al.Therapeutic Innovation & Regulatory Science|August 17, 2023
Identification of Confusing Medicine Proprietary Names: Toward Safe Medicine Use-A Cross-Sectional Study in Sri LankaManori Jayasinghe, Thotawaththage Loshadhi Indunika Srilal, Sewwandi Subasinghe, et al.Therapeutic Innovation & Regulatory Science|August 16, 2023
Characteristics of Asian Participation in Multi-regional Clinical Trials Reviewed for Drug Approval in Japan: Opportunities for Collaboration Between South-East Asia, East Asia, and JapanYoko Aoi, Yuta Kato, Kunihito Asano, et al.Therapeutic Innovation & Regulatory Science|October 27, 2023
Safety of Intravenous Pantoprazole Sodium in Pediatric Patients Aged 1 Month to < 1 Year: A Real-World Retrospective Cohort StudySampada Gandhi, Benjamin Taylor, Lexie Rubens, et al.Therapeutic Innovation & Regulatory Science|October 20, 2023
Comparison between European Medicines Agency and US Food and Drug Administration in Granting Accelerated Marketing Authorizations for Covid-19 Medicines and their Utilized RegulationsMarina Ghadanian, Ellen SchafheutlePageof 165